Samuel Whiting

Insider Reports History

Entity
Individual
Location
C/O Tempest Therapeutics, Inc., 7000 Shoreline Court, Suite 275, South San Francisco, CA
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Whiting:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. Chief Medical Officer Common Stock 9.57K $20.4K $2.13 Jul 2, 2024 Direct
Tempest Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 100K Jan 3, 2024 Direct

Insider Reports Filed by Samuel Whiting

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TPST Tempest Therapeutics, Inc. Jul 2, 2024 1 $9.95K 4 Jul 3, 2024 Chief Medical Officer
TPST Tempest Therapeutics, Inc. Jan 3, 2024 1 $0 4 Jan 5, 2024 Chief Medical Officer
TPST Tempest Therapeutics, Inc. Oct 11, 2023 1 $0 4 Oct 13, 2023 Chief Medical Officer
TPST Tempest Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Medical Officer
TPST Tempest Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 22, 2022 Chief Medical Officer
TPST Tempest Therapeutics, Inc. Jan 6, 2022 1 $8.17K 4 Jan 10, 2022 Chief Medical Officer
TPST Tempest Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 Chief Medical Officer
TPST Millendo Therapeutics, Inc. Jun 25, 2021 4 $0 4 Jun 30, 2021 Chief Medical Officer
TPST Millendo Therapeutics, Inc. Jun 25, 2021 0 $0 3 Jun 30, 2021 Chief Medical Officer